Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment complete in Peregrine phase II NSCLC trial

Oct. 7, 2011

Pfizer licenses neratinib to Puma Biotechnology

Oct. 7, 2011

New PLK1 inhibitors developed

Oct. 7, 2011

Bavarian Nordic gains rights to NCI anticancer vaccine candidate

Oct. 7, 2011

Millennium Pharmaceuticals discloses updated results from ongoing phase I trial of MLN-9708

Oct. 7, 2011

Study further elucidates activity of Adva-27a

Oct. 6, 2011

FDA accepts ridaforolimus NDA for filing

Oct. 6, 2011

Dosing begins in phase II PEG-rHuPH20 study

Oct. 6, 2011

Celgene and Agios Pharmaceuticals expand cancer metabolism partnership

Oct. 6, 2011

NDA for mechlorethamine gel accepted for review by FDA

Oct. 6, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...